Song Chen/China Daily] That climate change is becoming an increasingly bigger challenge for humankind was evident, more ...

Nearly 63% of the US population has fluoridated water flowing through their taps, according to the Centers for Disease ...

Chronic obstructive pulmonary disease (COPD) burden remains high in underdeveloped regions of China despite a decline in ...

AstraZeneca Plc isn’t the only health-care company facing compliance questions in China as concern continued to swirl about a ...

These jabs work by providing an instruction to the patient’s cells to churn out a particular protein that acts as a flag for ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

KEY TAKEAWAYS British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and ...

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

Wuxi International Life-Science Innovation Campus signed a strategic cooperation agreement with the Hong Kong Centre for ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Notably, the study also showed that treatment with pimicotinib provided statistically significant and clinically meaningful improvements in secondary endpoints associated with important patient ...

A husband and wife, both with the type of leukemia featured in the movie 'Dying to Survive,' have shared the stories of their long-term fight with the disease at the on-going CIIE.